|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1995; 25:619-625 © 1995 by the American College of Cardiology Foundation |
University of Ottawa Heart Institute, Ontario, Canada.
OBJECTIVES. This study compared the effects of amlodipine, atenolol and their combination on ischemia during treadmill testing and 48-h ambulatory monitoring. BACKGROUND. It is not known whether anti-ischemic drugs exert similar effects on ischemia during ambulatory monitoring and exercise treadmill testing. METHODS. Patients with stable coronary artery disease and ischemia during treadmill testing and ambulatory monitoring were randomized to receive amlodipine (n = 51) or atenolol (n = 49). Each group underwent a counterbalanced, crossover evaluation of single drug and placebo, followed by evaluation of the combination. RESULTS. Amlodipine and the combination prolonged exercise time to 0.1-mV ST segment depression by 29% and 34%, respectively (p < 0.001) versus 3% for atenolol (p = NS). During ambulatory monitoring, the frequency of ischemic episodes decreased by 28% with amlodipine (p = 0.083 [NS]), by 57% with atenolol (p < 0.001) and by 72% with the combination (p < 0.05 vs. both single drugs; p < 0.001 vs. placebo). Suppression of ischemia during exercise testing and ambulatory monitoring was similar in patients with and without exercise-induced angina. Exercise time to angina improved by 29% with amlodipine (p < 0.01), by 16% with atenolol (p < 0.05) and by 39% with the combination (p < 0.005 vs. placebo, atenolol and amlodipine). In patients with angina, total exercise time improved by 16% with amlodipine (p < 0.001), by 4% with atenolol (p = NS) and by 19% with the combination (p < 0.05 vs. placebo and either single drug). In those patients without angina, no therapy significantly improved total exercise time. CONCLUSIONS. Ischemia during treadmill testing was more effectively suppressed by amlodipine, whereas ischemia during ambulatory monitoring was more effectively suppressed by atenolol. The combination was more effective than either single drug in both settings.
This article has been cited by other articles:
|
|
 |
|
  N. Danchin Which patients would benefit the most from the perindopril-amlodipine combination? Eur. Heart J. Suppl., September 1, 2008; 10(suppl_G): G29 - G35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Enseleit and F. Duru Long-term continuous external electrocardiographic recording: a review. Europace, April 1, 2006; 8(4): 255 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Biagini, A F L Schinkel, J J Bax, V Rizzello, R T van Domburg, B J Krenning, M Bountioukos, C Pedone, E C Vourvouri, C Rapezzi, et al. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography Heart, June 1, 2005; 91(6): 737 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jneid, M. Chandra, M. Alshaher, C. A. Hornung, X.-L. Tang, M. Leesar, and R. Bolli Delayed Preconditioning-Mimetic Actions of Nitroglycerin in Patients Undergoing Exercise Tolerance Tests Circulation, May 24, 2005; 111(20): 2565 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Snow, P. Barry, S. D. Fihn, R. J. Gibbons, D. K. Owens, S. V. Williams, C. Mottur-Pilson, K. B. Weiss, and for the American College of Physicians/American Co Primary Care Management of Chronic Stable Angina and Asymptomatic Suspected or Known Coronary Artery Disease: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, October 5, 2004; 141(7): 562 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Chaitman, C. J. Pepine, J. O. Parker, J. Skopal, G. Chumakova, J. Kuch, W. Wang, S. L. Skettino, and A. A. Wolff Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina: A Randomized Controlled Trial JAMA, January 21, 2004; 291(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Cohn, K. M. Fox, and C. Daly Silent Myocardial Ischemia Circulation, September 9, 2003; 108(10): 1263 - 1277. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eccles, N. Rousseau, P. Adams, and L. Thomas Evidence-based guideline for the primary care management of stable angina Fam. Pract., April 1, 2001; 18(2): 217 - 222. [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Opie First line drugs in chronic stable effort angina--the case for newer, longer-acting calcium channel blocking agents J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1967 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jorgensen, S. Simonsen, K. Endresen, K. Forfang, K. Vatne, J. Hansen, J. Webb, C. Buller, G. Goulet, J. Erikssen, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) J. Am. Coll. Cardiol., March 1, 2000; 35(3): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rutledge, W. Linden, and R. F. Davies Psychological Risk Factors May Moderate Pharmacological Treatment Effects Among Ischemic Heart Disease Patients Psychosom Med, November 1, 1999; 61(6): 834 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF]
|
|
|
|
 |
|
 J.A.F.M. van der Vring, M.C.G. Daniels, N.J.H. Holwerda, P.J.A.M. Withagen, A. Schelling, T.J. Cleophas, and M.G.C. Hendriks Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers Angiology, June 1, 1999; 50(6): 447 - 454. [Abstract] [PDF]
|
|
|
|
|
|
D. Tzivoni, H. Kadr, S. Braat, W. Rutsch, J. A. Ramires, and I. Kobrin Efficacy of Mibefradil Compared With Amlodipine in Suppressing Exercise-Induced and Daily Silent Ischemia : Results of a Multicenter, Placebo-Controlled Trial Circulation, October 21, 1997; 96(8): 2557 - 2564. [Abstract] [Full Text]
|
|
|
|
 |
|
 Amlodipine, Atenolol Compared for Effects on Ischemia Journal Watch Cardiology, April 1, 1995; 1995(401): 2 - 2. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
